Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q1 2026 (March 31)6holders +1
1new positions
0sold out
$8.61avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($83K), PNC Financial Services Group, Inc. ($34K) and Accent Capital Management, LLC ($33K).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $33K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 4,514 shares bought and 983 shares sold, net +3,531 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Rhumbline Advisers | 0.00% | Reduce -6.8% | 9,643 | $83K |
| PNC Financial Services Group, Inc. | 0.00% | Add +18.2% | 3,944 | $34K |
| Accent Capital Management, LLC | 0.02% | New | 3,901 | $33K |
| Westside Investment Management, Inc. | 0.00% | No change | 2,229 | $20K |
| GAMMA Investing LLC | 0.00% | Reduce -15.0% | 1,597 | $14K |
| IMA Advisory Services, Inc. | 0.00% | Add +33.3% | 24 | $205 |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.